Drugs / YC-6
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03358901 | Dec 2016 → Dec 2017 | ischemic stroke | Guangzhou Cellprotek Pharmaceutical Co., Ltd. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | YC-6 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03358901 ↗ |
| Route | Intravenous | “dose-escalating intravenous infusion of YC-6” NCT03358901 ↗ |